Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 22263-22264 [2018-10224]

Download as PDF Federal Register / Vol. 83, No. 93 / Monday, May 14, 2018 / Notices 2. Legacy BancShares, Inc., Springdale, Arkansas; to merge with Gravett Bancshares, Inc., Gravette, Arkansas, and thereby indirectly acquire Bank of Gravett, Gravette, Arkansas. Board of Governors of the Federal Reserve System, May 9, 2018. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2018–10198 Filed 5–11–18; 8:45 am] BILLING CODE P Dr. Hana Pohl, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F–57, Atlanta, GA 30329. Telephone: 770.488.3355. Email: hrp1@cdc.gov. FOR FURTHER INFORMATION CONTACT: DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [Docket No. ATSDR–2018–0004] Availability of Draft Interaction Profile for Mixtures of Insecticides: Pyrethroids, Organophosphorus Compounds, and Carbamates Agency for Toxic substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Notice of availability; request for comments. AGENCY: The Agency for Toxic Substances and Disease Registry (ATSDR), within the Department of Health and Human Services (HHS) announces the availability of the Draft Interaction Profile for Mixtures of Insecticides: Pyrethroids, Organophosphorus Compounds, and Carbamates for review and comment. This interaction profile evaluates a mixture of chemicals often found in human blood, adipose tissue, and breast milk. The purpose of this interaction profile is to investigate the possible joint actions of these chemicals on endocrine, developmental, and neurobehavioral endpoints in humans. This interaction profile has undergone external peerreview and review by ATSDR’s Interagency Workgroup on Mixtures. ATSDR remains committed to providing a public comment period for these documents as a means to best serve public health and the public. DATES: Comments must be submitted by August 13, 2018. ADDRESSES: You may submit comments, identified by docket number ATSDR– 2018–0004, by any of the following methods: • Internet: Access the Federal eRulemaking Portal at www.regulations.gov. Follow the instructions for submitting comments. • Mail: Division of Toxicology and Human Health Sciences, Agency for amozie on DSK3GDR082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:02 May 11, 2018 Jkt 244001 Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F–57, Atlanta, GA 30329, Attn: Docket ATSDR–2018– 0004. Instructions: All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice. ATSDR develops interaction profiles for hazardous substances found at the National Priorities List (NPL) sites under Sections 104(i)(3) and (5) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA). This law requires that ATSDR assess whether or not adequate information on health effects is available for priority hazardous substances. Where such information is not available or under development, ATSDR shall, in cooperation with the National Toxicology Program, initiate a research program to determine these health effects. The Act further directs that, where feasible, ATSDR shall develop methods to determine the health effects of these priority hazardous substances in combination with other substances commonly found with them. To carry out these legislative mandates, ATSDR has created a chemical mixtures program and developed a document, ‘‘Framework for Assessing Health Impacts of Multiple Chemicals and Other Stressors,’’ that outlines the latest methods for mixtures health assessment. The Framework document is available online at https:// www.atsdr.cdc.gov/interactionprofiles/ ipga.html. In addition, a series of documents, called ‘‘interaction profiles,’’ is developed for certain priority mixtures that are of special concern to ATSDR. To recommend approaches for the exposure-based assessment of the potential hazard to public health, an interaction profile evaluates data on the toxicology of the whole priority mixture, if available, and on the joint toxic action of the chemicals in the mixture. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 22263 Availability The Draft Interaction Profile for Mixtures of Insecticides: Pyrethroids, Organophosphorus Compounds, and Carbamates is available online at https://www.atsdr.cdc.gov/ interactionprofiles/index.asp and at www.regulations.gov, Docket No. ATSDR–2018–0004. Pamela I. Protzel Berman, Director, Office of Policy, Planning and Partnerships, Agency for Toxic Substances and Disease Registry. [FR Doc. 2018–10204 Filed 5–11–18; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). This meeting is open to the public limited only by the space and ports available. The meeting room accommodates 70 participants and there will be 125 ports available. Due to the limited accommodations by phone ports and room size, we are encouraging the public to please register using the link provided: Register Here. There will be public comment periods from 11:10 a.m.–11:40 a.m., on June 19, 2018, and from 11:30 a.m.–11:45 a.m., on June 20, 2018. All public comments will be limited to two-minutes per speaker. DATES: The meeting will be held on June 19, 2018, 8:30 a.m.–5:15 p.m., EDT and June 20, 2018, 8:30 a.m.–12:15 p.m., EDT. ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus, 4770 Buford Highway, Building 107, Conference Room 1–A/B, Atlanta, Georgia 30341 and via Teleconference: Dial-In Number: 1–888–769–9404, Participant Code: 5536840. (U.S. & Canada Participants) 1–210–234–0065, Participant Code: 5536840 (International Participants). FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., SUMMARY: E:\FR\FM\14MYN1.SGM 14MYN1 amozie on DSK3GDR082PROD with NOTICES 22264 Federal Register / Vol. 83, No. 93 / Monday, May 14, 2018 / Notices M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–1430, Email address: NCIPCBSC@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board will: (1) Conduct, encourage, cooperate with, and assist other appropriate public health authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases, and other impairments; (2) assist States and their political subdivisions in preventing and suppressing communicable and noncommunicable diseases and other preventable conditions and in promoting health and well-being; and (3) conduct and assist in research and control activities related to injury. The Board of Scientific Counselors makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury prevention goals and provides evidence in injury prevention-related research and programs. The Board also provides advice on the appropriate balance of intramural and extramural research, the structure, progress and performance of intramural programs. The Board is designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters To Be Considered: Day One: The agenda will include discussions on Methodologies for Estimating Rates of Opioid Prescribing; a request and BSC vote to establish a workgroup to estimate, or provide reference points for, opioid prescribing for acute and chronic pain; the Center’s focus on science matters to include research strategies needed to guide the Center’s focus on reducing opioid overdose; and CDC and NIH research to reduce opioid overdose. Public comments on the formation of the Opioid Prescribing Estimates workgroup must be made during the comment period on June 19, 2018, 11:10 VerDate Sep<11>2014 18:34 May 11, 2018 Jkt 244001 a.m.–11:40 a.m. to be considered before the BSC vote. Day Two: The agenda will include discussions on reducing youth violence through CDC’s National Centers of Excellence in Youth Violence Prevention, and discuss improvements to Web-based Injury Statistics Query and Reporting System (WISQARS) data visualization. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2018–10224 Filed 5–11–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC–2018–0046, NIOSH– 313] Occupational Robotics Research Prioritization National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for information and comment. AGENCY: The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention has recently established the Center for Occupational Robotics Research. NIOSH is requesting information to guide the prioritization of research to be undertaken by the Center. NIOSH is seeking input on priority gaps in knowledge on the safety and health of humans working with robotics technology, with an emphasis on worker safety and health research which is unlikely to be completed by other federal agencies, academia, and the private sector. SUMMARY: Table of Contents • DATES: • ADDRESSES: • FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 • • • • SUPPLEMENTARY INFORMATION: BACKGROUND: INFORMATION NEEDS: REFERENCES: Electronic or written comments must be received by July 13, 2018. ADDRESSES: You may submit comments, identified by CDC–2018–0046 and docket number NIOSH–313, by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226–1998. Instructions: All information received in response to this notice must include the agency name and docket number [CDC–2018–0046; NIOSH–313]. All relevant comments received will be posted without change to www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to www.regulations.gov. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 45226–1998. FOR FURTHER INFORMATION CONTACT: Hongwei Hsiao, Ph.D., NIOSH Division of Safety Research, 1095 Willowdale Road, Morgantown, WV 26505, 304– 285–5910 (not a toll-free number), hhsiao@cdc.gov. SUPPLEMENTARY INFORMATION: Industrial robots have been a significant part of the workplace for decades. Within the last decade, there have been dramatic advances in robotics technology which have changed the types of work performed by robots and how robots interact with human workers. Whereas traditional industrial robots operate in cages or cells that are off-limits to human workers, newer types of robots are designed to work in collaboration with and in shared spaces with human workers. In collaborative operation, robots work in close proximity to humans and can potentially come into contact depending on the collaborative functionality implemented into the robot system. The use of robots has been rapidly increasing in many industrial sectors, including the manufacturing, healthcare, mining, and construction sectors. The International Federation of Robotics reported that the worldwide growth of industrial robots will be at least 15% annually from 2018 to 2020, and the stock of operational industrial robots will exceed 3 million units by the end of 2020 [IFR 2017]. Within the DATES: E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 83, Number 93 (Monday, May 14, 2018)]
[Notices]
[Pages 22263-22264]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10224]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC). This 
meeting is open to the public limited only by the space and ports 
available. The meeting room accommodates 70 participants and there will 
be 125 ports available. Due to the limited accommodations by phone 
ports and room size, we are encouraging the public to please register 
using the link provided: Register Here. There will be public comment 
periods from 11:10 a.m.-11:40 a.m., on June 19, 2018, and from 11:30 
a.m.-11:45 a.m., on June 20, 2018. All public comments will be limited 
to two-minutes per speaker.

DATES: The meeting will be held on June 19, 2018, 8:30 a.m.-5:15 p.m., 
EDT and June 20, 2018, 8:30 a.m.-12:15 p.m., EDT.

ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus, 
4770 Buford Highway, Building 107, Conference Room 1-A/B, Atlanta, 
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-769-9404, 
Participant Code: 5536840. (U.S. & Canada Participants) 1-210-234-0065, 
Participant Code: 5536840 (International Participants).

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,

[[Page 22264]]

M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-1430, Email address: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The Board of Scientific 
Counselors makes recommendations regarding policies, strategies, 
objectives, and priorities; and reviews progress toward injury 
prevention goals and provides evidence in injury prevention-related 
research and programs. The Board also provides advice on the 
appropriate balance of intramural and extramural research, the 
structure, progress and performance of intramural programs. The Board 
is designed to provide guidance on extramural scientific program 
matters, including the: (1) Review of extramural research concepts for 
funding opportunity announcements; (2) conduct of Secondary Peer Review 
of extramural research grants, cooperative agreements, and contracts 
applications received in response to the funding opportunity 
announcements as it relates to the Center's programmatic balance and 
mission; (3) submission of secondary review recommendations to the 
Center Director of applications to be considered for funding support; 
(4) review of research portfolios, and (5) review of program proposals.
    Matters To Be Considered: Day One: The agenda will include 
discussions on Methodologies for Estimating Rates of Opioid 
Prescribing; a request and BSC vote to establish a workgroup to 
estimate, or provide reference points for, opioid prescribing for acute 
and chronic pain; the Center's focus on science matters to include 
research strategies needed to guide the Center's focus on reducing 
opioid overdose; and CDC and NIH research to reduce opioid overdose. 
Public comments on the formation of the Opioid Prescribing Estimates 
workgroup must be made during the comment period on June 19, 2018, 
11:10 a.m.-11:40 a.m. to be considered before the BSC vote. Day Two: 
The agenda will include discussions on reducing youth violence through 
CDC's National Centers of Excellence in Youth Violence Prevention, and 
discuss improvements to Web-based Injury Statistics Query and Reporting 
System (WISQARS) data visualization. Agenda items are subject to change 
as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2018-10224 Filed 5-11-18; 8:45 am]
 BILLING CODE 4163-18-P